Cost effectiveness of liposomal doxorubicin vs. paclitaxel for the treatment of advanced AIDS–Kaposi’s sarcoma

Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients

2006 • 1,113 citations

Trends in cancer risk among people with AIDS in the United States 1980–2002

2006 • 752 citations

Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

1998 • 625 citations

Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group.

1998 • 354 citations

Paclitaxel Is Safe and Effective in the Treatment of Advanced AIDS-Related Kaposi's Sarcoma

1999 • 185 citations

Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma.

1998 • 175 citations

AIDS-Related Malignancies: Emerging Challenges in the Era of Highly Active Antiretroviral Therapy

2005 • 173 citations

Multicenter trial of low‐dose paclitaxel in patients with advanced AIDS‐related Kaposi sarcoma

2002 • 153 citations

Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus‐associated Kaposi sarcoma

2010 • 152 citations

Changing Physician Incentives For Cancer Care To Reward Better Patient Outcomes Instead Of Use Of More Costly Drugs

2012 • 59 citations

Neutropenia-Related Costs in Patients Treated with First-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer

2009 • 55 citations

Cost-Effectiveness Analysis Comparing Liposomal Anthracyclines in the Treatment of AIDS-Related Kaposi's Sarcoma

1998 • 26 citations

Cost-effectiveness of low-molecular-weight heparin for secondary prophylaxis of cancer-related venous thromboembolism

2005 • 25 citations

Cost-Effectiveness Analysis Comparing Chemotherapy Regimens in the Treatment of AIDS-Related Kaposi’s Sarcoma in Brazil

2006 • 19 citations

Cost-effectiveness Analysis of Pegylated-liposomal Doxorubicin and Liposomal Daunorubicin Treatments in Patients with Kaposi's Sarcoma

1999 • 18 citations

Therapy of special HIV-associated diseases: HCV-HIV-co-infection and AIDS-related Kaposi's sarcoma - official satellite to the 7th European Conference on Clinical Aspects and Treatment of HIV-infection, October 23, 1999 in Lisbon, Portugal.

1999 • 14 citations

Biology of Kaposi's sarcoma-associated herpesvirus

2005 • 13 citations

Documentation of Chemotherapy Infusion Preparation Costs in Academic- and Community-Based Oncology Practices

2006 • 12 citations

Phase III study of paclitaxel (Pac) versus pegylated liposomal doxorubicin (PLD) for the treatment of advanced human immunodeficiency virus (HIV)-associated Kaposi's sarcoma (KS): An Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium

2007 • 4 citations

ID6 Cost-Effectiveness of Liposomal Daunorubicin Versus Liposomal Doxorubicin in Kaposi Sarcoma

1998 • 3 citations

Cost effectiveness of liposomal Daunorubicin versus liposomal doxorubicin in Kaposi Sarcoma.

1998 • 2 citations